Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: "It is less surprising that neither story discussed costs, given that so few stories do. But sample costs could have been obtained by calling any of the numerous medical marijuana outlets in states where it is legal. Both stories did a decent job of quantifying the benefits.This story provided more details, though, including the differences in patient experiences between the three different concentrations of marijuana. It also repeated this important bit of information:""There was also no difference in the quality of life or mood scores that participants reported when they were on any of the four treatments."" The story also does a great job of pointing out that the treatment duration of five days in each dosage phase is too short to judge utility for chronic pain, which isa long-term affliction. Neither story actually quantified the harms, but they both noted there were side effects. This story did a better job, though, by noting that the only dose that seemed to work also seemed to produce the most side effects and by raising the issue of long-term safety concerns. It also was the only story to answer the question that readers surely would have when reading about an illegal narcotic being used as medicine. Did these patients feel high as a result? This story says that most did not. Because of the additional information and context, the rating here is satisfactory. This story, unlike the competing WebMD piece, establishes in the first sentence even in the first three words that this was ""a small study."" It then discusses the limitations of the study at several points. The second sentence says, ""The pain reduction was ""modest"" less than 1 point on an 11-point scale for the strongest marijuana and patients reported no overall difference in their quality of life based on what they smoked."" The writer elegantly and succinctly described the study design a complex randomized cross-over trial with double blinding and delved into an important feature of the study, that the subjects in retrospect may have been able to detect during which phase of their experience they inhaled placebo versus the most potent drug. This story avoids disease mongering, and, in fact, goes beyond that to note how few people actually suffer from the type of chronic pain that was the subject of the study:""About 1 to 2 percent of adults in the U.S."" The story quotes two outside experts, one of whom is completely independent from the study and the journal, Dr Andrea Hohmann. Beyond that, we would bet that the reporter spent more time interviewing Dr. Mark Ware, the lead researcher, or at least asked tougher questions. Because Ware is more measured in this story than in the WebMD story. He even goes so far as to say, ""What about long-term safety issues?"" he asked. ""These need to be considered before the drug becomes prescribable."" As with the WebMD story, it would have been nice to see who funded the research. Unlike the WebMD story, this one did not point out the conflicts of interest of Dr. Henry McQuay. This story talks about a range of treatment options and even has the study's lead author suggesting, that ""these patients should also be getting behavioral and physical therapy."" Strangely, neither story we reviewed pointed out that marijuana is illegal in most states and in Canada, where the study took place. The story could have, at a minimum, mentioned which states have medical marijuana laws or talked about whether any other countries currently allow cannabis to be sold in pill form the way it was used in this study. The story alludes to the fact that this study ""supports a limited number of trials that have suggested marijuana may be helpful for people suffering from chronic pain,"" indicating that the treatmentis not very novel at all. It would have been nice to see more context around that. The WebMD story provides a little more information in this regard. If the news release is to be believed, ""This is the first trial to be conducted where patients have been allowed to smoke cannabis at home and to monitor their responses, daily"". That could have been made clear. The story goes well beyond the release. Here's the release." Claim: Pot may provide some chronic pain relief: study
[A]: The story did a great job evaluating the evidence, providing outside voices, discussing alternatives to marijuana smoking, and presenting both the benefits and the potential harms. It could have done a better job discussing possible costs, availability and conflicts of interest. From the headline to the last sentence, this report avoided overstatement of the applicability of the potential benefit and used clear incisive language that left the reader with a good understanding of the study and its implications. This topic lends itself to jokey, pun-filled writing, but this story played it straight. Chronic pain can ruin lives, and a breakthrough with an alternative approach would be important news. As this story makes clear, until some larger studies with fewer limitations are undertaken, we are far from the point where marijuana can be considered a safe and effective treatment for chronic pain.

[Q]: Paragraph: Mustapha Redouane happily accepted the arrangement. He knew his mother's idea would silence the school's worries about his condition, a rare genetic disorder called xeroderma pigmentosum, or XP, which can make sun rays and other sources of ultraviolet light extremely damaging to the skin and eyes. The disorder is more common in North Africa than much of the world. "I hate the sun anyways. It gives me blisters," he said, sitting on his mother's lap, his face covered with the dark brown freckles that the school director considered a distraction to other students. Now 8, Mustapha has already had 11 operations to remove cancerous growths on his skin. His family is among thousands around the world struggling with XP, and increasingly sharing advice and seeking new treatments. In Morocco, families are also fighting for recognition, government help and the simple right to go to school. The disorder affects about 1 in 10,000 people in North Africa more than 10 times the rate in Europe and about 100 times the rate in the United States, according to Dr. Kenneth Kraemer, who researches XP at the U.S. National Institutes of Health. Because the disorder is inherited, XP is more common in populations where marriage between relatives is high, Kraemer said. Affected children inherit two copies of a mutated gene, one from each parent. A 2016 Moroccan government study estimates about 15% of marriages are between family members. Living in a country where the sun shines year-round makes them more susceptible to skin cancers that can be caused by the disorder, said Fatima El Fatouikai, pediatric dermatology specialist at the Ibn Rochd University Hospital in Casablanca. Without protection, few XP patients in Morocco live beyond their teenage years, El Fatouikai said. It is particularly challenging in developing countries, where an awareness of the disorder and access to treatments are scarce, and in poor, rural communities where people spend more time outside. Outside of El Fatoikai's office, families coming from all around Morocco sit in a waiting room eager for their names to be called. There is a rumor about a new XP treatment. The truth is, she says, "We only have prevention as a possible treatment. These children ... have to avoid even minimum sun exposure." The main prevention measures: avoiding the sun and wearing protective clothing, face shields and sunscreen. Fatimazehra Belloucy, 25, has dealt with skin cancer and other problems because of XP. "If only people made it easier. Their words hurt. I feel entirely alienated," she said, describing how she faces scared looks and hateful comments as she passes by. Her family limits interactions with her, fearful that the disease is contagious. "No one would take care of me, so I had to do it myself," said Belloucy, who received her high school diploma and is now enrolled in university. She hopes to land work helping with the disease. Most Moroccan children with XP don't continue their education. While U.S. schools install window filters for XP pupils and otherwise adapt to their needs, such accommodations are rare in Morocco. "It hurts me that I have to see little kids suffer because of lack of awareness," says Habib El Ghazaoui, who quit his veterinary job and made it his life's mission to raise awareness and help children with XP after learning that his daughter Fatimazehra had the disorder. His daughter, now a young adult raising awareness on social media, has had 50 operations for cancerous growths on her tongue, eyelids and elsewhere. She stays indoors and mostly sleeps during the day but, as the sun sets, she goes to parks and cafes, determined to lead a normal life. Ghazaoui leads the Association for Solidarity with Children of the Moon from his house in the town of Mohammedia. He juggles his time between visiting families, distributing donations of creams and masks, providing the Casablanca hospital with data and pressuring the government to take action. XP support groups are increasingly sharing advice online. They held an exceptional meeting in London last year to share "hundreds of practical hints" about hoods, window protections or meters to measure light and even a French-designed face shield with a fan in it, said NIH researcher Deborah Tamura. The donations from Ghazaoui's group reach families like those of Said El Mohamadi, a tailor in the city of Sale, whose 6-year-old daughter has the condition. His family is still debating the topic of school. "She's sad, but I can't risk taking her to school where there isn't any kind of protection," he said. "But she needs an education," her mother Maria El Maroufi pleads. ___ Nadine Achoui-Lesage and Mosa'ab Elshamy in Casablanca and Mohammedia contributed. Claim: When light is lethal: Moroccans struggle with skin disorder.
[A]: Determined for her 7-year-old son to attend school despite a life-threatening sensitivity to sunlight, Nadia El Rami stuck a deal with the school's director: Mustapha would be allowed in the classroom, but only if he studies inside a cardboard box.

[Q]: Paragraph: "Gov. Andrew M. Cuomo says women in New York state don't have to worry about new Trump administration rules ending a federal requirement that employers must include birth control coverage in their health insurance plans. The new rules exempt employers from the Obama-era mandate if they have religious or moral reservations to the coverage. But Cuomo said contraception will still be covered in New York state. ""This year, we ensured that whatever happens at the federal level, women in our state will continue to have cost-free access to reproductive health care,"" Cuomo said in a statement. States can set certain insurance standards beyond what the federal government requires. New York state told insurance companies in January they are required to cover birth control and abortion services. That condition still stands, but is Cuomo right that women in New York state are not affected by Trump's decision? Limits to state regulation State regulations, like the one from January, do not apply to all plans. The state Department of Financial Services regulates everything sold on the state health exchange, called New York State of Health. That includes plans sold to individuals and companies with 100 or fewer employees. The agency says the state's birth control mandate covers 1.35 million residents in those plans. Health care offered through companies with more than 100 employees is more complicated. Companies that go the traditional route of buying health coverage through an insurance carrier must adhere to the rules. About 2.5 million people in that category are covered by the state's birth control mandate. But companies that are self-insured, where the employer assumes a large part of the costs,are not regulated by the state, meaning they need not adhere to the state's birth control mandate. About 60 percent of private sector workers in the U.S. who get their health coverage through an employer were enrolled in a self-insured plan in 2015. That's up from 46 percent in 1996, according to research from the Employee Benefit Research Institute. In New York state, about 54 percent of private sector employees who get health insurance through their employer had a self-insured plan last year, according to the federal Agency for Healthcare Research and Quality. The option is most popular for companies with at least 1,000 employees. Eighty percent of private sector employees at companies that size in New York state are enrolled in a self-insured plan. What about public health insurance? The federal government sets the baseline for what services are covered under Medicaid. Government workers are covered under state regulation, but Medicaid and Medicare enrollees are not.States can add to that list. The list of services covered by Medicaid in New York state goes well beyond the federal standard. New York is one of multiple states where Medicaid covers birth control and abortion services. About a third of the state's population alone is on Medicaid. Our ruling Cuomo said women in New York state ""will continue to have cost-free access to reproductive health care"" because of an action the state took earlier this year. But not every woman is in an insurance planregulated by the state. It's possible a self-insured large employer in New York state could apply for an exemption from the federal birth control mandate. If granted the exemption, the company would not have to provide health coverage for birth control to its employees. Those exemptions are not expected to be widespread, but they are possible. Cuomo's statement needs clarification." Claim: Women in our state will continue to have cost-free access to reproductive health care
[A]:
Cuomo said women in New York state "will continue to have cost-free access to reproductive health care" because of an action the state took earlier this year. But not every woman is in an insurance planregulated by the state. It's possible a self-insured large employer in New York state could apply for an exemption from the federal birth control mandate. If granted the exemption, the company would not have to provide health coverage for birth control to its employees. Those exemptions are not expected to be widespread, but they are possible. Cuomo's statement needs clarification.